Here are relevant reports on : biopharmaceutical-market
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Excipients Market - Global Forecast to 2029
The global biopharmaceutical excipients market accounted for USD XX billion in 2023. It is projected to reach USD XX billion by 2029 from USD XX billion in 2024, at a CAGR of XX% during the forecast period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Strategic Analysis & Forecast of US Biopharmaceutical Industry – (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market
The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Global Forecast to 2029
The global biopharmaceutical process analytical technology market, valued at US$1.0 billion in 2023, stood at US$1.2 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2029, culminating in a forecasted valuation of US$2.6 billion by the end of the period. The market is witnessing a surge in growth propelled by rising investments, both direct and indirect, in analytical instruments, coupled with strategic partnerships aimed at advancing drug discovery.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) & Region - Global Forecasts to 2024
The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024, at a CAGR of 6.5%. The prominent players operating in the healthcare distribution market are McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Morris and Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), and CuraScript SD (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024
The global stable isotope labeled compounds market in terms of revenue was estimated to be worth $269 million in 2019 and is poised to reach $312 million by 2024, growing at a CAGR of 3.0% from 2019 to 2024. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Nanoparticle Analysis Market by Technology (DLS, NTA, XRD, SMPS, CPC, NSAM), Analysis Type (Size, Zeta Potential, Weight, Flow properties), End-user (Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions) - Global Forecast to 2020
This report studies the global nanoparticle analysis market over the forecast period of 2015 to 2020. The market is expected to reach USD 91.1 Million by 2020, at CAGR of 5.4% from 2015 to 2020. Rising focus on nanotechnology research, continuous advancements in nanoparticle analysis technologies, and increasing government spending on pharmaceutical R&D in emerging nations are key factors fuelling the growth of the nanoparticle analysis market. Increasing demand for customized medical implants, requirement of less sample volume and sample preparation in advanced analytical technologies, and stringent regulatory guidelines for drug approval are some other prime factors offering growth opportunities for players in the nanoparticle analysis market. However, high cost of nanoparticle analysis instruments is one of the key restraints for the market growth.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) - Global Forecast to 2024
The Filter Integrity Test Market is projected to reach USD 79 million by 2024, growing at a CAGR of 5.0%. Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the filter integrity test market. The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Solvent Evaporation Market by Evaporator Type (Rotary Evaporator, Nitrogen Blow Down Evaporator, Centrifugal Evaporator), End-User (Pharmaceutical & Biopharmaceutical, Diagnostic Laboratories, Research & Academic Institute), Region - Global Forecast to 2024
The solvent evaporators market is expected to grow from USD 487 million in 2019 to USD 694 million by 2024, at a compound annual growth rate (CAGR) of 7.3%. during the forecast period.The prominent players in the solvent evaporators market include Yamato Scientific Co., Ltd. (Japan), BÜCHI Labortechnik AG (Switzerland), Biotage AB (Sweden), Heidolph Instruments GmbH & CO. KG (Germany), Labconco Corporation (US), Porvair plc (UK), IKA Works GmbH & Co. KG (Germany), Steroglass Srl (Italy), Organomation Associates, Inc. (US), KNF Neuberger, Inc. (US), BioChromato, Inc. (Japan), Radleys (UK), LabTech S.r.l. (Italy), Abel Industries Canada Ltd. (Canada), DOÐA Limited (Turkey), ANPEL Laboratory Technologies Inc. (China), Asahi Glassplant Inc. (Japan), EYELA (Japan), Pope Scientific, Inc. (US), and SP Industries, Inc. (UK).
- Published: November 2019
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
